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Abstract

Dirofilaria immitis is a common and largely preventable mosquito-borne parasite that causes
dirofilariasis, or heartworm disease, in a number of animal species. The necessity of heartworm
prevention in the canine patient is undisputed and well-known among veterinary professionals,
yet there are still many dogs not protected from this fatal parasite. Heartworm prevention
traditionally requires a once-a-month administration of medication; therefore, its efficacy relies
on owner compliance. The barriers to canines receiving heartworm prevention were assessed
using a survey targeted at pet owners whose dogs have seen the veterinarian in the past year.
The main barriers identified were inadequate client communication and understanding,
expense of prevention, and forgetfulness. The goal of this research is to establish the barriers to
pets receiving monthly heartworm prevention so that veterinary professionals can be made
aware and work to address them in order to reduce the number of dogs infected.
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Introduction

The topic of heartworms and heartworm prevention is part of daily conversation for a
general practice veterinarian and their staff. A veterinary professional may talk with clients
about this disease upwards of ten times a day, but according to a 2019 study only 25% of dogs
are actually on consistent heartworm prevention (Johnson and Padgett.) Clients want to keep
their pets happy and healthy, and veterinarians want to help pet owners do just that. There are
so many diseases that even the best veterinarian cannot prevent or even treat, but heartworm
disease is not one of them. Recommending and giving heartworm prevention is a simple way to
prevent heartworms and keep pets healthy. So why are only 25% being protected from this
disease?
There is a disconnect between the scientific evidence that heartworm prevention is
necessary and what really happens when the pet leaves the vet clinic. In veterinary medicine
there is an intermediate between doctor recommendations and the care that the patient
receives: the client, or pet owner. It is the job of the veterinary professional to give clients the
tools they need and empower them to be an active part in their pet’s health. This research will
seek to identify the barriers to pets receiving heartworm prevention so that veterinary
professionals can address the barriers to better serve clients and prevent as many pets as
possible from contracting this fatal parasite. The barriers investigated will mainly focus on the
communication between the veterinary professional and the client, but also include factors
such as expense of prevention and forgetfulness.
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Background:
Life Cycle
Heartworm disease is a serious, life-threatening disease caused by infection with
Dirofilaria immitus, a parasitic worm. The canine patient is a definitive host for this parasite and
the pulmonary artery is its preferred final destination. The life cycle for this parasite begins
when any of up to seventy mosquito species draws a blood meal from an animal infected with
heartworms (Aiello and Moses 127.) The mosquito ingests larval stage 1 (L1) of the parasite,
known as microfilaria. The parasite matures from L1 to L3 in the mosquito over a period of 1030 days and migrates from the gut to the mouth parts (Barnette and Ward.) L3 is considered
the infective stage of Dirofilaria immitus, at this stage the mosquito can infect a canine through
a bite. Once a patient is infected, within 3-9 days the parasite matures to stage L4 in the
subcutaneous tissue and migrates through the tissues and muscle fibers. The parasite molts
one last time between day 50 and day 70 as they migrate through the body into the circulatory
system. These immature adults can reach the pulmonary vasculature as early as day 67
(American Heartworm Society [AHS] 9-10.) The worms mature in the pulmonary arteries and
can reach up to 12 inches in length (AHS 10.) Once the female worm is sexually mature, she will
begin to release microfilaria, or larval stage 1. Microfilaria can be detected in the blood of an
infected patient as early as six months after infection. From this point on this patient is a danger
to other dogs as mosquitos can become infected from feeding on the patient and begin the
cycle once again, infecting animals up to one hundred miles away. The American Mosquito
Control Association states that most species of mosquitos have flight ranges of one to three
miles, but some have been known to migrate up to one hundred miles. Microfilaria may survive
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for up to two years in the patient waiting for the mosquito to arrive and become the
intermediate host but left untreated the adult worms will continue to produce new microfilaria
(Aiello and Moses 128.)
Clinical Signs
The presence of heartworms in the canine heart is disruptive to the natural physiology
of the body, and this manifests through many different clinical signs. The worms initially live in
the pulmonary arteries, but as their size and numbers grow, they can invade the right ventricle,
right atrium, and even the vena cava (AHS 10.) Adult worms typically live for three to five years
in the patient and during that time they are altering the normal function of the heart (Aiello and
Moses 128.) Merck Veterinary Manual states “Live adult heartworms cause direct mechanical
trauma, and other suspected factors (eg, antigens and excretions) are thought to directly
irritate or stimulate the hosts’ immune system to damage vessel intima…. the presence of dead
worms leads to more severe vascular reactions and subsequent lung pathology…” (Aiello and
Moses 128.) The residence of the worms in the heart and the damage they inflict there can
cause clinical signs in other areas of the patient. Barnette and Ward list the most obvious
clinical signs of heartworm disease as a soft, dry cough, shortness of breath, weakness,
listlessness, and loss of stamina. Unfortunately, by the time these clinical signs are noticed the
parasites have already done permanent damage to the heart muscle.
Parasite presence in the heart causes the heart to work harder to contract, resulting in
hypertrophy of the muscle and eventual decrease in the blood flow out of the heart and
increased pressure. If the disease is far enough progressed this heart enlargement is significant
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enough to be seen on radiographs. This heart enlargement puts pressure on and can even
displace the trachea dorsally, this pressure is the cause of the signature cough associated with
heartworm disease. The patient experiences weakness and loss of stamina due to the increased
workload on the heart to perform its function. If the heart is already struggling to meet
demands when the patient is at rest, it’s inadequacy will become apparent with exercise. The
patient will have an increased respiratory rate and a decreased activity level. Shortness of
breath occurs when the ability of the heart to pump blood to the lungs is compromised. The
presence of the worms impedes the natural blood flow of deoxygenated blood from the right
side of the heart to the lungs. This back-up of blood can also cause ascites, or a buildup of fluid
in the abdomen. At this point, the heart has begun to fail.
Unfortunately, when the disease has progressed to heart failure there is little to be done
to improve the quality of life for the patient or the time they have left. When a client brings
their pet to the veterinarian with symptoms such as cough, exercise intolerance, and ascites the
damage to the heart is extensive and permanent which means only the symptoms can be
managed. It takes years for heartworm disease to progress to this stage; when caught early
through annual heartworm testing, there is a conversation to be had about treating the
heartworms to prevent heart failure and the symptoms associated with it.
Testing
The American Heartworm Society recommends annual heartworm testing for all canines
regardless of clients’ compliance with heartworm prevention. There are several reasons why a
patient on heartworm prevention may still contract heartworms including forgotten or late
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doses, or a patient vomiting or rubbing off prevention. Even with perfect heartworm prevention
compliance there is still a small chance of infection with prevention-resistant parasites. An
annual heartworm test ensures that the disease can be caught in its earliest stages to discuss
treatment options before permanent damage is done. Additionally, a patient should be tested
before beginning heartworm prevention if their history on prevention is unknown or
inconsistent. Starting a patient with a high parasite load on heartworm prevention can cause
dangerous side effects, therefore the risks should be assessed and discussed with the client
before beginning prevention.
There are two broad types of heartworm tests: antigen testing with an enzyme-linked
immunosorbent assay (ELISA) test and microfilaria testing, most commonly performed by
examining a blood sample under the microscope. The American Heartworm Society
recommends both an antigen and microfilaria test be performed annually due to the possibility
of both tests giving false negatives in unique circumstances (16.) The ELISA test is the most
sensitive and tests for the presence of the adult heartworms themselves through detection of
an antigen produced by the adult female parasite, but antigen-antibody complexes can cause
false negative results (AHS 16.) The ELISA test is the most used for annual testing of
asymptomatic patients and when seeking a result for a suspected positive patient (Aiello and
Moses 130.) The microfilaria testing can give a false negative result because about twenty
percent of positive patients are not microfilaremic, and that figure is higher for patients on
prevention (AHS 17.)
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Treatment
Heartworm “treatment” can mean a variety of different things and employ different
drugs and protocol, but generally refers to the administration of an adulticide, a medication
that kills adult heartworms. The recommended treatment plan can vary based on the patient’s
symptoms (or lack thereof) and other factors such as age and activity level. The only adulticide
approved for heartworm treatment is melarsomine dihydrochloride. Merck Veterinary Manual
states that melarsomine is given at a 2.5mg/kg dose intramuscularly in the epaxial musculature
in the area of the third to fifth lumbar vertebrae (133.) This drug is an arsenic containing
compound and carries the risk for side effects from local reaction at the injection site to sudden
death caused by a pulmonary thromboembolism. A pulmonary thromboembolism occurs when
a piece of dead heartworm dislodges into circulation and causes a blockage in the lungs. The
risk of this deadly occurrence can be reduced by strictly reducing activity and excitement of the
patient through methods such as cage rest and leash walking to use the bathroom.
Melarsomine is often given in conjunction with other medications the most common of
which being doxycycline and prednisone. Doxycycline is given to kill Wolbachia pipiens, a
bacterium necessary for normal maturation, reproduction, and infectivity of the heartworm. If
Wolbachia are killed the adult heartworm gradually dies (Aiello and Moses 128.) Prednisone
helps control the clinical signs of pulmonary thromboembolism during treatment. The following
table shows the American Heartworm Association recommended protocol for the treatment of
adult heartworms.
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Figure 1 (AHS 25) American Heartworm Association recommended protocol for the
management of adult heartworms.
Some patients are simply not a candidate for treatment due to the toll it takes on the body such
as geriatric patients and those with advanced disease. The risk for severe and deadly side
effects of the melarsamine injections significantly increases in patients who are exhibiting
symptoms such as a cough. Additionally, treatment may not be an option due to the financial
constraints of the client. The AHS states that the average cost of treatment for a forty-pound
dog is between $1,200 and $1,800 including all medications and diagnostics. The patient’s
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veterinarian may recommend a variation of the mentioned medications and protocol to fit the
patient’s individual circumstances. One of the alternative methods is the long-term use of
heartworm prevention to kill the adult heartworms slowly over time.
The slow kill method of treatment is not recommended by the AHS but is an intermediate
between the “gold standard” of care and no treatment at all. The clients budget often plays a
large role in the use of this method. In this approach monthly ivermectin with or without
doxycycline and prednisone is given and will shorten the lifespan of the adult heartworm. Most
notably, the adulticide melarsamine is not used in this method. According to the AHS it has
been shown to take over two years for the adult heartworms to die using this method (30.)
During that time the disease is progressing as the worms are still causing damage to the heart
muscle. Additionally, these patients continue to serve as a vector for the parasite because the
adult heartworms are still reproducing and releasing microfilaria into circulation to be ingested
by a mosquito. It is also mentioned that this method contributes to resistant subpopulations of
heartworms (AHS 30.)
Prevention
There are many different drugs and brand names classified as heartworm prevention,
but all of them are in the same class of macrocyclic lactones and serve the same purpose: kill
heartworms and their life stages. Heartworm prevention kills all stages of the parasite except
L2, which resides only in the mosquito. However, as mentioned, the prevention alone can take
years of consistent use to kill L6, or adult heartworms. The intended use of heartworm
prevention is to kill L3 as soon as it enters the patient via a mosquito bite before it has time to
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mature and cause harm to the patient. Heartworm preventative will protect against L3 and L4
stages for the time period that it is labeled for, beyond that time period protection is
unpredictable.
Prevention-resistant parasites have been recognized; however, “lack of efficacy” events
are better explained by other causes such as failure to administer the prevention at the proper
dose and frequency and failure of sufficient absorption of the active ingredient due to emesis
(AHS 10.) A study conducted to review patients that tested positive for heartworm antigen
while on heartworm prevention found that 80.7% of these patients had a gap in administration
of prevention. Only 1.7% of cases had no purchase gaps and no factors that could influence or
indicate insufficient administration of heartworm preventive (Atkins et al 109.) While resistance
has been identified, it is not common. Macrocyclic lactones are highly effective and one of the
safest medications used in veterinary medicine when administered according to label
instructions (AHS 9.)
Clients have several routes of administration to choose from for their dogs’ heartworm
prevention: topical, oral, and parenteral. Oral preventatives are designed for the patient to eat
freely when given; they are often in the form of a chew and contain a flavor additive to aid in
palatability of the medication. The somewhat recent addition of an injectable option
administered by a veterinarian allows clients who may not be able to administer medication to
their pet a safe, effective option for heartworm prevention. Additionally, the injectable form
comes in a six-month and twelve-month formulation relieving the client of a monthly
responsibility. However, this convenience comes at a cost that not all pet owners can afford;
many clients still elect a monthly preventative.
9

For the most part, veterinarians see healthy patients once a year. The client brings their
pet in for an exam and vaccinations, and they are mentally “checked off” for an entire year. In
one visit that may last fifteen minutes veterinary staff must impress the importance of
heartworm prevention on the client well enough for them to make it a point to give their pet
prevention every thirty days. To prevent this disease, clients must take their pets health into
their own hands when the veterinary staff is no longer there. Clients must see the value in
giving the prevention both to carry out the proper administration and to justify the cost of the
prevention.
Not only must we impress upon the client the necessity of monthly heartworm
prevention, but also the need for annual heartworm testing at an additional expense. The
nature of the disease is such that no symptoms will be noticed until extensive permanent
damage has been done. It is difficult for all parties involved to find out that a pet has a fatal
disease that was completely preventable and could have been treated if caught early. When the
disease is caught early through annual testing treatment is still extensive, expensive, and
difficult on the pet. The best situation is for canine patients to receive consistent, veterinarian
recommended heartworm prevention twelve months out of the year.
There are many factors involved as to why pets do not receive heartworm prevention
and annual testing. These factors will be explored using the results of a survey targeted at dog
owners whose pets have seen a veterinarian in the past year. Once identified, veterinary
professionals can seek to find more ways to support pet owners in protecting their dogs from
this disease.
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Methods and Procedures
The scientific evidence of heartworm life cycle, disease, and prevention has been laid
out to show the indisputable fact that consistent, veterinarian recommended heartworm
prevention is medically necessary for canine patients. This research seeks to find the barriers to
pets receiving this medication through a survey targeted at pet owners, the individuals
responsible for purchasing and administering heartworm prevention. The target of the survey
was clients whose pets have been seen by a veterinarian in the past year due to the fact that
heartworm prevention is a prescription medication that requires an exam by a veterinarian. The
hypothesis is that the clients whose pets who do not receive heartworm prevention are simply
unaware of its necessity or confused about which products to use and their administration, thus
leading one to believe the issue lies in the communication between veterinary professionals
and clients.
The survey was approved by the Murray State Institutional Review Board and was
estimated to take no longer than ten minutes to complete. Participants were made aware of
their rights to decline to answer questions or leave the survey entirely once beginning as well as
a reasonable assurance of confidentiality. The survey consisted of multiple choice, open
response, and select all that apply questions as well as an opportunity to add any additional
thoughts. At the close of the survey a statement advising participants to contact their
veterinarian with any questions regarding their pets’ health was included. The Google Forms
survey and participation consent can be found in the appendices.
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The survey was disseminated in an online format through Facebook with the title
“Barriers to Client Compliance and Understanding of Heartworm Prevention in the Canine
Patient.” A flier with a link to the survey was also advertised in various pet-related businesses
and parks. The survey was available to the public for three weeks. Due to the nature of the
primary investigators circle of peers a larger than average number of respondents were
formally educated or employed in the field of veterinary medicine. This is acknowledged as
causing somewhat of a bias in results; however, these responses can be separated and analyzed
independently due to a specific yes or no question about formal education or employment in
the field of veterinary medicine. It is also acknowledged that results will be skewed due to the
title of the survey indicating its subject matter of heartworm prevention. Potential participants
uneducated in this matter may have chosen not to respond due to their lack of knowledge
and/or interest. The percentage of pets receiving heartworm prevention may be inflated, but
the information regarding barriers should provide a reasonably full picture.
Results
The survey received one hundred and seventeen responses in the twenty-five days it was
available. The participants represented the care of two hundred and twenty-eight canines. All
participants were the primary caretaker of at least one dog, and 99.1% of those participants
owned dogs over the age of six months. Due to the overwhelming majority of canines
represented being over 6 months, the results will not be skewed by patients who are too young
to receive prevention. It is noted that the one participant with a young dog indicated that they
had already started giving prevention and planned to continue as prescribed.
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Over 99% of participants indicated that a veterinary professional had spoken with them
about heartworm prevention. The most common professional to speak with clients about
heartworm prevention was the veterinarian at 95.6% followed by the technician and
receptionist at 41.6% and 14.2% respectively. Figure 1 shows how well the client understood
what was being discussed.

Figure 2. Pie charts reflecting the responses of participants when asked to identify how well
they understood why heartworm prevention was recommended as well as understanding of
when and how to give prevention.
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The percentage of participants that indicated anything other than the correct answer of
once monthly or every thirty-day administration when asked how often oral/topical prevention
should be given was 15.7. This question received only 102 answers out of the 117 participants.
A majority (67.5%) of participants indicated the importance of heartworm prevention as a ten
out of ten. The full spread of responses can be seen in Figure 3.

Figure 3. Bar graph showing the number of responses from zero to ten when participants
were asked to rank how important giving heartworm prevention is.
All participants answered the question “Is your dog(s) on heartworm prevention,” 83.8%
indicated “yes” and zero participants responded “unknown.” If one were to exclude all
responses from participants formally educated or employed in the field of veterinary medicine
the percentage of “yes” responses would be slightly lower at 82.1%. Seventy-four percent of
participants indicated that they strive to give prevention year-round and 10.4% strive to give it
only during the warm months of the year. One participant indicated that they strive to give
prevention once every three months, and the remaining responses indicated that they do not
give any prevention. Figure 4 indicates how many months out of the year participants actually
14

manage to give prevention. The majority of participants indicated that they give prevention
twelve months out of the year.

Figure 4. Pie chart reflecting how many months out of the year participants administer
heartworm prevention. Colors light purple, dark blue, and red represent eleven, ten, and nine
months respectively.
Participants who do not give any heartworm prevention were asked to identify a reason,
twenty-three responses were collected. Finances was a factor for 34.7% of respondents, 30.4%
used their pet’s low likelihood of infection as rational, and 13% indicated that they do not
believe prevention is effective at preventing heartworms. Each of the following sentiments was
indicated by at least one participant: heartworm prevention is deadly, forgetfulness, and not
having time for a veterinary appointment. A total of thirty-nine responses were collected from
the question asking participants who give some prevention but not 12 months out of the year
to indicate why. This was a select all that apply question. One third of participants said they did
not believe prevention was necessary in the winter/cooler months and an additional one third
said they forget to give prevention. Twenty point five percent of participants indicated that
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they forget to buy prevention, 5.2% indicated expense, and 2.6% said it was because their pet
rarely goes outside.

Figure 5. Pie charts reflecting participant responses regarding annual heartworm testing and
rational for lack of testing.
When asked to explain why they declined the annual heartworm test the overwhelming
majority listed that they did not believe it was necessary if their pet was on year-round
prevention. There were two responses that mentioned cost and risk factor.
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When participants were asked if they would like more information on heartworms and
how to protect their dog 86.5% indicated “no.” Below in figure 5 are the parting thoughts of
participants that the investigator deems relevant to the research. For the sake of transparency
all spelling and grammatical errors are included.

Would you like to add anything?
I don’t think that it’s stressed nearly enough to clients that most prevention needs to be
given regularly and on the same day every month. I am a vet tech major which is how I know
that, but I didn’t know it before I entered this program. I also don’t think there’s enough
emphasis on needing to do it year round, or at least there wasn’t by my vet that i take my
dogs to.
My dog had heart worm while taking a heart worm preventative.
Do the research before giving any heartwork or flea and tick prevention. It may save your
dogs life. These are insecticides you are feeding your babies.
For years I gave the monthly meds, no heartworm. Then I quit since dogs are inside dogs,
and for years now, no heart worm. That makes me question whether the meds are necessary
for indoor mostly dogs.
I found even if I gave heartwork pills to my dog every month he still has to be tested to see if
he has it. That makes no sense. He was taking all year long n being tested. Just to get money
for test. Prices of both pills n test should not be so expensive n people would get more often.
It’s just too expensive!!!
When I have issued in the past it has been for just not remembering or running out of meds.
I wish the vet would like send me reminders texts about the meds. It's not thier
responsibility, but it would be nice it there was like a automated system to prompt me.
We love our dog very much, however, going to the vet is expensive so we choose to take
care of him best we can and pay our doctor visits instead. Sad but true
The best conversation I had was when the vet said “using ours allows liability coverage, if he
gets heart worms we would cover it through the medical provider” - however it can seem
like just another overused sales pitch for some. I know I paid $250 more for a neuter once
with all the “additional testing” plus my vet requires a $50+ exam fee even if my dog doesn’t
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get all the exams. I don’t blame people for thinking heart worms are just another thing to be
overcharged for
It is difficult to get my veterinarian to fax a prescription to online pharmacy. They refuse.
There are cheaper methods than listed
Unfortunately multiple things that aid in the animals general health are not available without
a vet. Adding larger costs for something that should be more adorable if it was the animals
well being not the vets well being in mind.
Since Covid, the vet tech comes to the car to get the dog. I have minimal to no interaction
with the vet
Make it OTC
Some heartworm preventative is not working the way it should. For example heart guard is
known in the vet world to be one of the preventatives that dogs are coming back positive
even if they have been on it for years.
Thank you for doing the survey! Heartworm is a horrible, preventable illness that more
owners should be aware of. I have always had Great Danes and made sure they got their
monthly dose.
I asked my vet but they said it’s not a concern, I’m in Southern California- that may explain it
My daughter took in a dog that heart worms. We learned a lot at that time about it.
Although prevention is costly so is the treatment. Luckily it’s been 7 years and he’s st ill going
strong. The treatment saved his life.
I had a dog I adopted from the island of Antigua where nearly every dog has heartworms.
She was positive. Luckily there was no obvious damage and she was able to be treated once
in the states. Treatment is very expensive and it’s hard on dogs. It was sad not to see her be
able to run for quite a while. I wanted to share my own experience of having a heartworm
positive dog and going through treatment.
Would like to know other opinions about heartworm protection in our state of AZ
Figure 6. Direct, unedited feedback from participants at the end of the survey. Comments not
relevant to the research have been excluded from this list.
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Analysis
The hypothesis was that the lack of heartworm prevention use is due to lack of
communication between the client and veterinary professional both on the overall discussion
of heartworm existence and the clients understanding of the large risk they can pose to their
pets’ health. The overwhelming majority of participants (96.6%) had been educated by a
veterinary professional and, as figure 1 shows, a relatively low number of participants did not
agree with the statement of understanding why prevention was being recommended and
how/when to administer it at 11.1% and 7.7% respectively. However, there is a disconnect
between participants answer on whether or not they understood how and when to give
prevention and the reality, which can be measured by their answer to the fill in the blank
question of how often to give oral/topical prevention. Only 7.7% of respondents reported not
knowing how/when to give prevention, but over double that number answered the question
incorrectly (15.7%) and fifteen participants elected not to answer this question, leading one to
believe that they did not know how to respond. This means it could be concluded that up to
25% of participants did not know how often to give prevention. This indicates client confusion;
the veterinary professional may have said one thing, but the client heard something different
and believes their pet is fully protected, when in reality they are not.
Eighty-three point eight participants responded “yes” they give heartworm prevention,
but when the products they reported administering are analyzed it is seen that 20.5% of those
respondents are only giving flea and tick prevention. Many of the participants in this category
ranked the importance of giving heartworm prevention at a ten out of ten. These respondents
believe that they are protecting their pet from heartworm disease, but that is not the case. This
19

leaves only about 60% of participants pets actually receiving heartworm prevention. It can be
concluded from this data that veterinary professionals are doing an excellent job of bringing up
the topic of heartworms to their clients, but the effectiveness of the discussion can be
improved.
Client confusion about how and when to give prevention can lead to misconceptions
that heartworm prevention is not effective. When participants who do not give any heartworm
prevention were asked for a rational 13% indicated that they do not believe heartworm
prevention is effective. If the clients pet tests positive for heartworms they believe it was due to
the medication being ineffective when in reality it was being administered incorrectly or not at
all. This begins a domino effect of miscommunication and in some instances leads the client to
believe the veterinary practice is only sees heartworm prevention and testing as a means to
make a profit. Evidence of this thought can be seen in figure 5.
Ten point four percent of participants only give heartworm prevention during the warm
months of the year. According to the data collected, about 30.4% of clients that do not give
year-round prevention use low risk of infection as a rational. It is not clear from the data
collected what level of understanding the clients have about their pets’ risk of infection. Many
clients perceive their inside dogs’ risk to be low enough that the expense or inconvenience of
prevention is not worth it, and while indoor pets’ risk may be lower than an outdoor pet, there
is still a chance of infection.
About one fourth of participants whose dogs do not have an annual heartworm test
done responded that they decline the annual heartworm test. The overwhelming majority
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indicated in short-answer format that they do not believe it is necessary if their pet is on
heartworm prevention. As mentioned, about 20% of respondents who indicated that they give
heartworm prevention are only giving flea and tick prevention and an additional 22.2% do not
give prevention twelve months out of the year. The pets of these participants are left
vulnerable to heartworm disease with or without client knowledge. Heartworm disease is not
recognized until some degree of permanent damage has been done to the heart muscle, so
annual testing is highly recommended.
Analysis of the survey results revealed the following major barriers to pets receiving
heartworm prevention: client confusion, forgetfulness, and finances. Since up to 25% of
participants do not know when and how to give prevention and 20% believe they are giving
heartworm prevention but are not, a large barrier to pets receiving prevention is client
confusion. Client forgetfulness is also prevalent with 53.8% of participants indicating they forget
to give prevention and/or forget to buy prevention on a select-all-that-apply question. Finances
also play a role for some clients with 34.7% of participants listing it as a rational for their pet
not receiving any prevention.
Conclusion
Veterinary professionals are doing an excellent job of broaching the topic of heartworm
prevention with their clients, but survey results indicate the either the quality of the
conversation or the level of client understanding can be improved, or both. A trip to the
veterinarian can be stressful for pets and clients whether it is due to bad memories, the hassle
of transporting a pet, finances, or otherwise. This stress can cause important information to be
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missed by the client. Clients are only exposed to this onslaught of potentially overwhelming
information one time per year. Topics can include when to spay or neuter, changes in health
seen on physical exam, and other preventatives in addition to any concerns the client has when
bringing their pet in. It is easy for the information about heartworm prevention to go in one ear
and out the other. Clients should be exposed to this information in more ways than one and
more times than once. This includes having the entire veterinary team participate in education
from the first face they see when checking in to the technician and veterinarian.
A study performed by Partners for Healthy Pets using five years of compiled data from
surveys of pet owners and veterinary staff indicates that pet owners do not always understand
what the staff believes they are communicating to them. Communication is arguably the most
important aspect of veterinary medicine and inadequacies in this area cause many pets to go
without prevention. The twenty percent of clients who believe they are giving prevention but
are in fact only administering flea and tick prevention are an example of inadequate
communication with the veterinary team. Clients should be aware of the products they are
giving their pets and it is the veterinary professionals’ responsibility to help them navigate the
overwhelming amount of product options to select products that are appropriate for the
patient. Receptionists should be aware of the products that their practice carries and what
parasites they cover so they can assist clients during checkout and educate the clients who are
only purchasing flea and tick preventative.
Receiving information auditorily can only go so far, especially when the amount of
information is large, and the topic may be foreign to clients. Placing visual client education tools
in exam rooms such as a chart displaying different types of heartworm prevention, a model
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heart infected with parasites, or a poster with disease prevalence in the area can improve
clients understanding and help them see how serious heartworm disease is. Another low-cost
option to expose clients to this information is to post information or even do trivia about
heartworms on social media pages. It may also be helpful to send clients with a pamphlet
explaining what was discussed and that highlights important take-aways so that they are
relieved of trying to remember everything that was said and can digest the information at a
later time or discuss it with co-owners. The more times and ways clients receive this
information the better they will understand and the more likely they are to remember to give
prevention.
It is important for veterinary professionals to remember to give clients all the
information about why they are recommending heartworm prevention. Clients are more likely
to comply if they understand the why behind the cost and inconvenience. It can be easy to
simply state that prevention is recommended and once the client agrees move on to another
topic. This same premise applies with heartworm testing, if it is offered and the client declines
it is easiest to end the conversation there. However, veterinary professionals need to ensure
clients understand what they are declining or why they are agreeing to give a medication. If a
client quickly agrees to give prevention but does not understand why it is important it is much
easier for them to discontinue use for any of the reasons mentioned such as perceived risk of
infection, expense, or inconvenience without fully realizing the implications of their decision. If
the veterinary professional has not discussed their pets risk level the client is left to their own
devices to determine what they believe the risk to be. A client that agrees without being given
all the information may purchase a dose when prompted, but never return for the next month’s
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dose. Clients should be made aware of what end-stage heartworm disease looks like, the
expense of treatment, and a realistic idea of their pets’ risk of infection. It is the responsibility
of the veterinarian to make sure clients can make an educated decision about their pet’s
health, regardless of what that decision may be.
It is worth noting that communication between the veterinary professional and client
was severely impeded during the COVID-19 pandemic. Many veterinary clinics were offering
only curbside service and face-to-face interaction was strictly limited. This period lasted for a
minimum of six months and up to over a year for some locations. New pet owners may have
missed a critical period in forming a relationship with their veterinarian. Most communication
during this time was happening over the phone which is inhibitory due to the loss of non-verbal
cues. Since keeping a distance from clients was a necessity during this time, important
information such as the heartworm prevention discussion may have been missed. This lapse of
in-person communication heightens the need to discuss heartworm prevention with all canine
owners regardless of the number of previous visits or assumed knowledge. Many clients still
elect to continue curbside veterinary services either for safety or convenience. Veterinary
professionals should be ensuring that these clients are still receiving the same level of
education that would be given in an exam room.
Expense of heartworm prevention and testing was a common barrier for clients getting
this care for their pet. Unfortunately, changing the cost of procedures and medication is not a
feasible solution. A step that can be taken to help lower this barrier is education about the cost
of owning a pet. Many people do not consider this expense, or veterinary expenses in general,
when purchasing a pet. Lifelong heartworm prevention is an investment in the health and
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longevity of a canine companion, just as any other preventative measure. In some cases, once
clients understand how important this medication is they can justify the cost. A veterinarian is
well versed in accommodating client budget into providing care for a patient. Simply identifying
this barrier can go a long way in helping a pet get the best care within a budget as opposed to
no care. Communication and education are the veterinary professionals’ only practical tools to
combat the barrier of expense.
Forgetfulness is perhaps the most straightforward and easy to remedy barrier. A
monthly responsibility can be difficult to remember for clients with busy lives. Veterinary
professionals have several options to help clients overcome this barrier to consistent
protection. The practice can post reminders on social media, recommend putting reminders on
smartphones and calendars, and inform clients of reminder programs. Many heartworm
prevention manufactures offer programs that will remind clients to give prevention with a text
or email. When clients share their struggle with forgetfulness, it is a great opportunity to
educate them on why annual testing is so highly recommended.
Veterinary professionals want to protect as many canine patients as possible from the
fatal parasite dirofilaria immitis, but the only way is through client cooperation. Three main
causes of client non-compliance have been identified to help veterinary professionals see
where they are lacking in terms of getting patients on prevention. Many of these barriers are
not unique to heartworm prevention but are encountered in almost every aspect of veterinary
medicine: expense and client misunderstanding. Speaking honestly and frequently with clients
and checking their understanding is the only way to overcome these barriers. Heartworm
disease can be complex and difficult to understand, especially for a client, but taking the time
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to ensure their understanding will pay off with prevention compliance and fewer patients
diagnosed with heartworm disease.
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Appendix A
Informed Consent Document

Thank you for taking the first step to participate in the undergraduate research of Emily
Fischels! This survey will be used to investigate the use and understanding of heartworm
prevention in dogs. Participation in this study is voluntary. You are free to leave questions blank
or exit the survey at any time with no fear of repercussions. Please answer the questions
honestly, there will be no judgement of answers perceived to be “right” or “wrong” by the
investigator or involved parties. Participants will remain anonymous; no identifying information
will be collected. However, the investigator cannot guarantee confidentiality or eliminate all
possibility of risk through an online survey platform.
Participation in this study may not benefit you directly, but it will help veterinarians better
serve pets and their owners by understanding the barriers to pets receiving consistent
heartworm prevention.
This research is overseen by Dr. Laura Ken Hoffman assistant professor at Murray State
University as well as Honors College Executive Director, Dr. Warren Edminster.
If you have any questions or concerns about this study, please contact:
Primary investigator: Emily Fischels (efischels@murraystate.edu)
Faculty Advisor: Dr. Laura Ken Hoffman (lhoffman2@murraystate.edu)
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Appendix B
Survey Questions
By checking "I agree", you are acknowledging that you understand your above rights AND that
you are 18 years of age or older. *
I agree
Are you the primary caretaker of at least one dog?
Yes
No
Are you a student or alumni of the MSU Veterinary Technology Program or are you
employed/formally educated in the field of veterinary medicine?
Yes
No
Has your dog(s) been seen by a veterinarian in the past year?
Yes
No
Is your dog(s) 6 months of age or older?
Yes
No
How many dogs over the age of 6 months do you have?
Has a veterinary professional (veterinarian, technician, receptionist, etc.) ever talked to you
about heartworms/heartworm prevention?
Yes
No
If so, which professional?
Veterinarian
Veterinary technician: usually the individual in scrubs who you first speak with in the room
Receptionist
Unknown
Other:

If yes, please select the most correct answer to the following statements.
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I left the conversation with a full understanding of why heartworm prevention was
recommended.
Strongly Agree
Agree
Neither agree nor disagree
Disagree
Strongly disagree
N/A
I left the conversation with a full understanding of when and how to give heartworm
prevention.
Strongly agree
Agree
Neither agree nor disagree
Disagree
Strongly Disagree
N/A
If a veterinary professional has never spoken to you about heartworm prevention, were you
already aware of it before taking this survey?
Yes
No
N/A
How important do you feel giving heartworm prevention is?
Extremely unimportant
0
1
2
3
4
5
6
7
8
9
10
Extremely important
Is your dog(s) on heartworm prevention?
Yes
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No
Unknown
Please check all products that your pet is on for heartworm and/or flea and tick prevention.
Trifexis
Nexgard
Heartgard
Comfortis
Advantage Multi
Frontline
Frontline Plus
Interceptor Plus
Simparica
Simparica Trio
Proheart 6
Proheart 12
Revolution
Sentinel
Bravecto
Other:

Please indicate how often oral/topical heartworm prevention SHOULD be given

I strive to give my dog heartworm prevention… *either by giving monthly preventative or by
Proheart injections given by a veterinarian*
Year-round
Only during the warm months of the year
I do not give heartworm prevention
Other:

My pet actually receives heartworm prevention ___ months out of the year

If your pet does not receive any heartworm prevention, why is that?
The prevention is too expensive
I am not aware of the need for prevention
My dog does not go outside or goes out only to use the bathroom and therefore cannot
contract heartworms
I am aware of heartworms and do not believe prevention is effective
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I am aware of heartworms and do not believe they would negatively impact my dogs’ health
if contracted
N/A
Other:

If your pet receives some heartworm prevention but not 12 months out of the year, why is
that? Select all that apply
I don’t believe it is necessary in the winter/cooler months
I forget to give prevention
I forget to buy prevention
Other:

Does your dog receive an annual heartworm test?
Yes
No
Unknown
Sometimes
If not, why is that?
I decline the annual heartworm test
I have never been offered a heartworm test for my dog
My dog has not been to the vet’s office
If you decline the annual heartworm test, please explain why
Would you like more information about heartworms and how to protect your dog?
Yes
No
Would you like to add anything?
Please speak to your veterinarian about any questions related to your dog’s health including
heartworms and heartworm prevention. Thank you for participating in my research!
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